Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma

Annals of Surgical Oncology

Volumn 11, Issue 3, 2004, Pages 265-273

  Canter, Robert J ^a   Zhou, Rong ^a   Kesmodel, Susan B ^a   Zhang, Yawei ^a   Heitjan, Daniel F ^a   Glickson, Jerry D ^a   Leeper, Dennis B ^b   Fraker, Douglas L ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acidification; Human melanoma xenografts; Isolated limb perfusion; MIBG

Indexed keywords

(3 IODOBENZYL)GUANIDINE; GLUCOSE; MELPHALAN; ALKYLATING AGENT; ANTINEOPLASTIC AGENT;

ANIMAL MODEL; ARTICLE; CANCER MORTALITY; CELL PH; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIZATION; FEMALE; HYPERGLYCEMIA; LIMB PERFUSION; MELANOMA; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; RAT STRAIN; TUMOR GROWTH; XENOGRAFT; ANIMAL; ANIMAL DISEASE; CHEMISTRY; DISEASE MODEL; DRUG INTERACTION; HUMAN; INTRACELLULAR FLUID; METHODOLOGY; PATHOLOGY; PH; RANDOMIZATION; REGIONAL PERFUSION; SKIN TUMOR;

3-IODOBENZYLGUANIDINE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERGLYCEMIA; INTRACELLULAR FLUID; MELANOMA; MELPHALAN; RANDOM ALLOCATION; RATS; SKIN NEOPLASMS;

EID: 2442670656     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.05.019     Document Type: Article

References (30)

1. Fraker DL. Hyperthermic regional perfusion for melanoma and sarcoma of the limbs. Curr Probl Surg 1999;36:841-907.
2. Manusama ER, Nooijen PT, Stavast J, et al. Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat. Br J Surg 1996; 83:551-5.
3. Bauer TW, Gutierrez M, Dudrick DJ, et al. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan. Surgery 2003;133:420-8.
4. Kelley ST, Menon C, Buerk DG, et al. Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. Surgery 2002;132: 252-8.
5. van den Berg AP, van den Berg-Blok AE, Kal HB, Reinhold HS. A moderate elevation of blood glucose level increases the effectiveness of thermoradiotherapy in a rat tumor model. I. Relative contributions of glucose and heating to tumor acidification. Int J Radiat Oncol Biol Phys 2001;50:783-92.
6. Volk T, Jahde E, Fortmeyer HP, et al. pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 1993;68:492-500.
7. Jahde E, Rajewsky MF. Tumor-selective modification of cellular microenvironment in vivo: effect of glucose infusion on the pH in normal and malignant rat tissues. Cancer Res 1982;42:1505-12.
8. Ekelund S, Nygren P, Larsson R. Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology. Biochem Pharmacol 2001;61:1183-93.
9. Biaglow JE, Manevich Y, Leeper D, et al. MIBG inhibits respiration: potential for radio- and hyperthermic sensitization. Int J Radiat Oncol Biol Phys 1998;42:871-6.
10. Kuin A, Aalders M, Lamfers M, et al. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG). Br J Cancer 1999;79:793-801.
11. Loesberg C, Van Rooij H, Nooijen WJ, et al. Impaired mitochondrial respiration and stimulated glycolysis by m-iodobenzylguanidine (MIBG). Int J Cancer 1990;46:276-81.
12. 31P magnetic resonance spectroscopy study. Cancer Res 2000;60:3532-6.
13. Heitjan DF, Manni A, Santen RJ. Statistical analysis of in vivo tumor growth experiments. Cancer Res 1993;53:6042-50.
14. Lindstrom ML. Bates DM. Nonlinear mixed effects models for repeated measures data. Biometrics 1990;46:673-87.
15. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
16. Gleadle JM, Ratcliffe PJ. Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 1997;89:503-9.
17. Maxwell PH, Dachs GU, Gleadle JM, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1997;94:8104-9.
18. Leeper DB, Engin K, Wang JH, et al. Effect of i.v. glucose versus combined i.v. plus oral glucose on human tumour extracellular pH for potential sensitization to thermoradiotherapy. Int J Hyperthermia 1998;14:257-69.
19. Mastrangelo S, Tornesello A, Diociaiuti L, et al. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer 2001;84:460-4.
20. Kushner BH, Yeh SD, Kramer K, et al. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy. J Clin Oncol 2003;21:1082-6.
21. 131I] iodobenzylguanidine. J Nucl Med 1980;21:349-53.
22. 131I]MIBG radionuclide therapy in carcinoid syndrome. Eur J Surg Oncol 2002;28:243.
23. Burd R, Wachsberger PR, Biaglow JE, et al. Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors. Cancer Res 2001;61:5630-5.
24. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-65.
25. Matsuyama S, Llopis J, Deveraux QL, et al. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2000;2:318-25.
26. Park HJ, Lyons JC, Ohtsubo T, Song CW. Acidic environment causes apoptosis by increasing caspase activity. Br J Cancer 1999; 80:1892-7.
27. Kozin SV, Shkarin P, Gerweck LE. The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics. Cancer Res 2001;61:4740-3.
28. Griffiths JR. Are cancer cells acidic? Br J Cancer 1991;64: 425-7.
29. Siemann DW, Chapman M, Beikirch A. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy. Int J Radiat Oncol Biol Phys 1991;20:287-9.
30. Skarsgard LD, Skwarchuk MW, Vinczan A, et al. The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake. Anticancer Res 1995;15:219-23.